Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable - Fitch Research

Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable

Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable - Fitch Research
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable
Published Sep 26, 2014
1704 words — Published Sep 26, 2014
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable 26 Sep 2014 3:08 PM (EDT) Fitch Ratings-Chicago-26 September 2014: Fitch Ratings has affirmed Pfizer Inc.'s (Pfizer's) ratings, including the 'A+' Issuer Default Rating (IDR). The rating...

  
Report Type:

Press Release

Company(ies)
Wyeth LLC , Pfizer Inc. , Pharmacia LLC
Ticker(s)
Issuer
Pharmacia Corp.
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable" Sep 26, 2014. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Affirms-Pfizer-s-IDR-at-A-Outlook-Stable-883754_pr_frame>
  
APA:
Fitch Research. (). Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable Sep 26, 2014. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Affirms-Pfizer-s-IDR-at-A-Outlook-Stable-883754_pr_frame>
  
US$ 149.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.